The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Greek Supreme Court To Rule On Legality Of Referendum

Fri, 03rd Jul 2015 10:15

LONDON (Alliance News) - The following is a summary of top news stories Friday.
----------
COMPANIES
----------
The Royal Bank of Scotland Group could face a penalty of as much as USD13 billion depending on the outcome of a US mortgage securities lawsuit, Bloomberg News reported. According to the report the US Federal Housing Finance Agency, which is suing on behalf of Fannie Mae and Freddie Mac, estimated that amount in a court filing in a related case.
----------
Anglo-Dutch consumer goods giant Unilever said it has agreed to buy US skincare company Murad. Terms of the deal were not disclosed. Founded in 1989 in Los Angeles, Murad, which had a turnover of USD115 million in 2014, will be incorporated into Unilever's Prestige division. The Murad deal follows Unilever's recent acquisitions of Dermalogica, Kate Somerville and REN.
----------
Ofcom has fined mobile operator EE GBP1 million for failing to comply with rules on handling customer complaints, the UK media and communications regulator said. EE is currently in the process of being acquired by telecoms company BT Group. The Ofcom investigation found EE did not provide certain customers with accurate or adequate information about their right to take their complaint to an alternative dispute resolution during the period under review, which covered July 22, 2011 to April 8, 2014.
----------
GlaxoSmithKline's ViiV Healthcare signed a strategic manufacturing agreement with Desano Pharmaceuticals on Thursday for the manufacturing of dolutegravir, ViiV's HIV medicine. The agreement will offer an additional source of the dolutegravir active pharmaceutical ingredient and will allow ViiV to offer a competitive supply of the finished product, marketed under the name Tivicay, for China and a number of developing countries, subject to national approvals.
----------
Ferrexpo said pellet production rose in the second quarter and in the first half as the company continues to produce more high-quality pellets. The iron ore miner operating in Ukraine said total pellet production in the second quarter experienced a small lift to 2.9 million tonnes, bringing total first half production to 5.8 million tonnes, which is up 8.3% from 5.4 million tonnes a year earlier.
----------
MARKETS
----------
London shares are mostly lower mid-morning, trading in a narrow range with the US stock market closed and ahead of the Greek referendum on its bailout provisions on Sunday.
----------
FTSE 100: down 0.3% at 6,610.30
FTSE 250: down 0.4% at 17,625.08
AIM ALL-SHARE: up 0.5% at 765.41
----------
The pound was higher against the dollar after UK Markit services Purchasing Manager's Index, the day's only domestic economic data, came in ahead of expectations.
----------
GBP: up at USD1.5632
EUR: up at USD1.1113

GOLD: up at USD1168.20 per ounce
OIL (Brent): down at USD61.69 a barrel

(changes since end of previous GMT day)
----------
ECONOMICS AND GENERAL
----------
Greek officials were braced for a decision by the country's supreme administrative court on the legality of the bailout referendum ahead of rival campaign rallies in central Athens. According to the Council of Europe, a democracy watchdog, Sunday's referendum will not meet international standards, as voters have not been given enough time to prepare and the question posed is too vague. But Triantafyllia Lina Papadopoulou, a professor of constitutional law at the Aristotle University of Thessaloniki, says the referendum is unlikely to be challenged. "Even if they go into the substance, I think it will be too late to annul the referendum," she told dpa.
----------
Greece requires at least EUR36 billion from Eurozone over the coming three years on concessional terms to maintain its finances sustainable, the International Monetary Fund said in a report. In a preliminary draft of its Greek debt sustainability analysis, the IMF said the funding requirement is projected to reach around EUR50 billion from October 2015 to end 2018, requiring at least EUR36 billion from European creditors on highly concessional terms.
----------
The UK service sector logged strong growth in June following a temporary lull in May linked to the recent election. The headline Markit/Chartered Institute of Procurement & Supply Purchasing Managers' Index rose to 58.5 in June from a five-month low of 56.5 in May. It was forecast to rise to 57.5. Data suggests that the second quarter of 2015 was the strongest on average since the third quarter of 2014.
----------
Ireland's service sector expanded at the fastest pace in almost nine years in June, driven by continued gains from improvements in economic conditions, survey figures from Markit Economics and Investec showed. The Investec services Purchasing Managers' Index rose to 63.3 in June from 61.4 in the previous month. A reading above 50 indicates expansion in the sector. The services activity increased at the strongest pace since September 2006.
----------
China's securities market regulator said that it has opened an investigation into suspected market manipulation. The China Securities Regulatory Commission said it has set up a team to look for "clues of illegal manipulation across markets" and irregularities between securities and futures trading."Those suspected of a crime will be resolutely transferred to the police for investigation," spokesman Zhang Xiaojun said in comments on the regulator's official microblog Thursday.
----------
The services sector in China continued to expand in June, but at a slower pace, the latest PMI from HSBC Bank showed, with a PMI score of 51.8. That's down from 53.5 in May, although it remains above the line of 50 that separates expansion from contraction. The composite index came in at 50.6, down from 51.2 in the previous month and touching a 13-month low.
----------
Iran sent mixed messages on whether it is ready to accept intrusive nuclear inspections foreseen in a deal with six world powers, following a visit by International Atomic Energy Agency chief Yukiya Amano in Tehran. Amano was expected to report back Friday in Vienna to the group of six, which are negotiating with Iran on scaling back the Islamic republic's nuclear programme and allow deep scrutiny by IAEA inspectors, in return for sanctions relief.
----------
An airstrike has killed a leading Islamic State fighter in Syria, the Pentagon said. Tunisian militant Tarik bin Tahar al-Awni al-Harzi was killed in Syria near the border with Iraq on June 16. His death would make it harder for Islamic State to move weapons and fighters in and out of Iraq and Syria, Pentagon spokesman Jeff Davis said in a statement.
----------
Syrian opposition rebels launched a large-scale attack on regime strongholds in the northern province of Aleppo, killing and wounding some 80 people, a monitoring group said. "This is the heaviest attack by rebel forces Aleppo has witnessed since two years, as more than 400 shells fell on regime-held areas in Aleppo," Rami Abdel Rahman, head of the Syrian Observatory for Human Rights, told dpa.
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.